NGS-based characterization of transgene insertion to manufacture viral vector producer cell lines and immunotherapy products

24 June 2021Webinars

4 PM CET / 10 AM ET


Registration opening soon.

© 2012-2021 Cergentis B.V. All rights reserved.
For Research Use Only.Not for use in diagnostic procedures.
We use cookies for website analysis and marketing. By visiting and using our website you accept these cookies.